Trial Radar
Sign in

NCT lookup

Pull any trial record directly from ClinicalTrials.gov.

Genotype Information and Functional Testing Study
Genotype Information and Functional Testing Study

NCT00992420

CompletedN/A

Sponsor: Scripps Health

Conditions: Coronary Artery Disease

Countries: United States

This study is a sub-study of GRAVITAS (clinicaltrials.gov identifier NCT00645918). The purpose of this study is to assess which genes influence residual platelet reactivity on standard dose clopidogrel therapy, and also to determine whether certain genes influence the incremental change in platelet reactivity with high-dose clopidogrel maintenance dosing in patients who have high residual platelet reactivity on standard dosing.

Eligibility overview

Sex: ALL

Age: 18 Years to —

Healthy volunteers: No

Study type: OBSERVATIONAL

Eligibility criteria
Inclusion Criteria:

* Patients meeting inclusion criteria for GRAVITAS who undergo VerifyNow blood sampling for VerifyNow P2Y12 platelet function testing and IVRS entry for GRAVITAS randomization/selection determination

Exclusion Criteria:

* See GRAVITAS trial (ClinicalTrials.gov identifier: NCT00645918)
Locations (1)
  • La Jolla, California, United States